Author(s): U. Viplava Prasad, M. Syam Bab, B. Kalyana Ramu
DOI: 10.5958/0975-4377.2017.00007.6
Views:
58
(pdf),
5597
(html)
Access:
Open Access
Cite: U. Viplava Prasad, M. Syam Bab, B. Kalyana Ramu. Sensitive Visible Spectrophotometric methods Development for Estimation of Sapropterin Dihydrochloride in tablet dosage form. Res. J. Pharm. Dosage Form. & Tech. 9(1): Jan.-Mar. 2017; Page 33-37. doi: 10.5958/0975-4377.2017.00007.6
Read More
|
Author(s): U. Viplava Prasad, M. Syam Bab, B. Kalyana Ramu
DOI:
Views:
18
(pdf),
3453
(html)
Access:
Open Access
Cite: U. Viplava Prasad, M. Syam Bab, B. Kalyana Ramu. Assay of Tolterodine Tartrate in Bulk and Capsule Formulations by using Simple and Affordable Visible Spectrophotometric Methods. Research J. Pharma. Dosage Forms and Tech. 2012; 4(4): 211-215. doi:
Read More
|
Author(s): K. Raghubabu, V. Jagannadharao, B. Kalyana Ramu
DOI:
Views:
13
(pdf),
3223
(html)
Access:
Open Access
Cite: K. Raghubabu, V. Jagannadharao, B. Kalyana Ramu. Development and validation of extractive visible spectrophotometric methods for determination of ropinirole hydrochloride in pharmaceutical dosage forms based on ion-association complex formation. Research J. Pharma. Dosage Forms and Tech. 2012; 4(3): 172-176 . doi:
Read More
|
Author(s): B. Kalyana Ramu, M. Syam Bab, U. Viplava Prasad
DOI:
Views:
17
(pdf),
3133
(html)
Access:
Open Access
Cite: B. Kalyana Ramu, M. Syam Bab, U. Viplava Prasad. A Novel visible spectrophotometric method development for the estimation of oseltamivir phosphate in capsules based on ferric hydroxamate reaction. Research J. Pharma. Dosage Forms and Tech. 2013; 5(2): 70-74 doi:
Read More
|
Author(s): K. Raghubabu1, V. Jagannadha Rao, B. Kalyana Ramu, G. Chandra Sekhar , Srinivasa Rao
DOI:
Views:
9
(pdf),
2788
(html)
Access:
Open Access
Cite: K. Raghubabu1, V. Jagannadha Rao, B. Kalyana Ramu, G. Chandra Sekhar , Srinivasa Rao. Validated Visible Spectrophotometric Methods Development for the Assay of Ropinirole Hydrochloride in Pharmaceutical Preparations. Research J. Pharma. Dosage Forms and Tech. 2012; 4(5): 267-271 . doi:
Read More
|